PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Record numbers expected at CPHI & PMEC China 2024 as Asian markets boom

Domestic and international markets in Asia surging as CPHI & PMEC China welcomes 60,000 attendees and 3500 exhibitors Shanghai/Amsterdam: CPHI & PMEC...
Continue Reading →
News

KCL researchers identify key features of autoimmune diseases present in the gut

Globally affecting 4% of the population, autoimmune diseases mistakenly attack healthy cells, tissues and organs in the body. Researchers from King’s College Lond...
Continue Reading →
News

Vicore and Endeavor’s therapies show promise in treating IPF

Both drugs have the potential to offer a disease-modifying approach to the lung disease. Vicore Pharma and Endeavor BioMedicines have shared new data from two mid...
Continue Reading →
News

Study finds link between malaria parasites developing antimalarial drug resistance

Spread through Anopheles mosquitoes, the disease affected around 249 million people globally in 2022. Researchers from the Antimicrobial Resistance (AMR) Interdis...
Continue Reading →
News

Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients

The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK. Researchers from Imperial College London (ICL), the Alan Turin...
Continue Reading →
News

ELRIG UK Announces Profs Ijeoma Uchegbu and Marcus Schindler as Keynote Speakers at Drug Discovery 2024 

Drug Discovery 2024: Connecting Minds, Transforming Science, Empowering Community will take place at ExCeL London from 2–3 October The European Laboratory Researc...
Continue Reading →
News

During BIO Show, PCI Pharma Services to Highlight Sterile Fill-Finish Robotics Technologies at Nearby San Diego Manufacturing Plant

Robotics-assisted systems support sterile filling of vials, prefilled syringes and cartridges during clinical trials, substantially limiting drug product loss while ...
Continue Reading →
News

Unveiling the Agenda for the Chemspec Europe 2024’s Conferences

The 37th edition of Chemspec Europe 2024, the International Exhibition for Fine and Speciality Chemicals, is to be held from 19th to 20th June in Hall 3 at the Messe...
Continue Reading →
News

Limerston Capital Backed Cormica Announces First US Acquisition With New Jersey Based TPM Laboratories

Seven-figure purchase underlines ambitions to be a global leader UK-based medical device and pharmaceuticals testing group, Cormica, has completed the seven-figur...
Continue Reading →
News

Francis Crick Institute and Broken String Biosciences partner for ALS research

The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK. The Francis Crick Institute and Broken String Biosciences ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026